Diabetes

By Jonah Comstock March 3, 2017
Implantable longterm continuous glucose monitor company Senseonics is in a better place than its financials would suggest. The company posted a net loss of $9.9 million last quarter, up from an $8.4 million loss in the year prior, and is planning to borrow about $5 million from the Oxford Silicon Valley Bank that it’s already $20 million in debt to. But Senseonic’s potentially game-changing...
By Jonah Comstock February 12, 2017
More than two years ago, when Apple first added a list of diabetes management apps to its app store, we covered the list of 13 top picks. A lot can change in a few years, however. And while a few of those same apps still appear on Apple’s current list of 12 diabetes management apps, there’s plenty of new names — though not all new to MobiHealthNews readers — as well. Read on for Apple’s current...
By Jonah Comstock January 19, 2017
Updated with statement from Eli Lilly Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's rapid-acting insulin. The clearance is for prescription use, but includes two versions of the app: Go Dose, for patients, and Go Dose Pro, for healthcare providers. "...
By Heather Mack January 5, 2017
Diabetes management device maker Intuity Medical has raised another $15 million in Series C funding in a round led by PTV Healthcare Capital, new investors KCK Group, and affiliates of Luther King Capital Management. Existing investors Accuitive Medical Ventures, Investor Growth Capital, US Venture Partners, Venrock and Versant Ventures also contributed to the round. The company, which makes an...
By Heather Mack December 2, 2016
Germantown, Maryland-based Senseonics, which is working on a long-term implantable continuous glucose monitor called Eversense, has expanded its exclusive distribution agreement with Roche. Now, Roche will have exclusive rights to promote, market and sell the Eversense product line to diabetes clinics and patients in in most of Europe (excluding Scandinavia and Finland), the Middle East (except...
By Jonah Comstock November 17, 2016
Dr. Dennis Ausiello, director of the Center for Assessment Technology and Continuous Health (CATCH) at Massachusetts General Hospital, says the smartphone is “the greatest medical device ever made”. As part of a talk at the Xconomy Forum in Boston today, Ausiello spoke about some lessons learned from GlucoSuccess, the Apple ResearchKit project launched by CATCH. “The thing that we learned was...
By Heather Mack November 17, 2016
Eli Lilly and Company has developed an app for people living with Type II diabetes who use Trulicity, the company’s once-per-week injectable diabetes medication that also works with a click-activated pen. The app, which has been fully functionally since September, is currently available free on iOS to anyone with a Trulicity prescription. “It’s important for people to successfully start any...
By Heather Mack November 16, 2016
Mountain View, California-based Livongo Health, a chronic disease management company, has launched a new capability on its smart blood glucose meter. The device now employs one of the most basic – yet perhaps underrated – features of a smartphone: the ability to download over-the-air updates. The Livongo meter, a smart glucose meter that the company says is the first such device to offer...
By Heather Mack November 11, 2016
Israel-based DarioHealth, which makes a smartphone-connected blood glucose monitor, has made significant headway in the US, Australian and Canadian markets, seling 5,500 devices in the US this quarter and 8,500 worldwide. The company launched in the US in March, and quickly built up a customer base with more than 100 percent increase in growth by the second quarter. Coasting on that wave of new...
By Heather Mack November 9, 2016
A new tool to diagnose diabetes is in the works, and it’s a far cry from the often painful and invasive method of drawing blood. Researchers at the University of Oxford are developing a portable device, similar to breathalyzers used to detect blood alcohol level, that they believe can potentially diagnose diabetes non-invasively and monitor glucose levels. Head researchers Robert Peverall and his...